Alterations in microRNA Expression during Hematopoietic Stem Cell Mobilization
- PMID: 34356523
- PMCID: PMC8301406
- DOI: 10.3390/biology10070668
Alterations in microRNA Expression during Hematopoietic Stem Cell Mobilization
Abstract
microRNAs play an important role in the regulation of gene expression, cell fate, hematopoiesis, and may influence the efficacy of CD34+ cell mobilization. The present study examines the role of hsa-miR-15a-5p, hsa-miR-16-5p, hsa-miR-34a-5p, hsa-miR-126-3p, hsa-miR-146a-5p, hsa-miR-155-5p, and hsa-miR-223-3p in the course of hematopoietic stem cell mobilization. The numbers of CD34+ cells collected in patients with hematological malignancies (39 multiple myelomas, 11 lymphomas) were determined during mobilization for an autologous hematopoietic stem cell transplantation. The miRNA level was evaluated by RT-PCR. Compared to baseline, a significant decline in hsa-miR-15a-5p, hsa-miR-16-5p, hsa-miR-126-3p, hsa-miR-146a-5p, and hsa-miR-155-5p was observed on the day of the first apheresis (day A). An increase was observed only in the expression of hsa-miR-34a-5p. On day A, a negative correlation was found between hsa-miR-15a-5p and hsa-miR-146a-5p levels and the number of CD34+ cells in peripheral blood. A negative correlation was observed between hsa-miR-146a-5p and the number of collected CD34+ cells after the first apheresis. Good mobilizers, defined according to GITMO criteria, demonstrated a lower hsa-miR-146a-5p level on day A than poor mobilizers. Patients from the hsa-miR-146a-5p "low expressors" collected more CD34+ cells than "high expressors". Our results suggest that the investigated miRNAs, especially hsa-miR-146a-5p, may influence the efficacy of HSC mobilization.
Keywords: CD34+; hematopoietic stem cells; hsa-miR-146a-5p; miRNA; mobilization; multiple myeloma.
Conflict of interest statement
The authors have no conflict of interest that are directly relevant to the content of this paper.
Figures




References
-
- Devine S.M., Flomenberg N., Vesole D.H., Liesveld J., Weisdorf D., Badel K., Calandra G., DiPersio J.F. Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin’s Lymphoma. J. Clin. Oncol. 2004;22:1095–1102. doi: 10.1200/JCO.2004.07.131. - DOI - PubMed
-
- Nowicki M., Wierzbowska A., Małachowski R., Robak T., Grzybowska-Izydorczyk O., Pluta A., Szmigielska-Kaplon A. VEGF, ANGPT1, ANGPT2, and MMP-9 expression in the autologous hematopoietic stem cell transplantation and its impact on the time to engraftment. Ann. Hematol. 2017;96:2103–2112. doi: 10.1007/s00277-017-3133-4. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources